Nodular Ganglioneuroblastoma — Clinical Trials

MONDO:00033254 active·2 recruitingLast updated: Mar 20, 2026, 7:06 PM

Trial Landscape

Nodular Ganglioneuroblastoma has an emerging clinical trial program, driven by procedure and drug treatment.

Recruiting

Active Trials

By Approach

Procedure4

Drug Treatment3

Biological Therapy3

2 additional trials involve behavioral, dietary, diagnostic, or observational approaches.

By Phase

Phase 2

Phase 3

Sponsor Types

Collaborative Network3NIH1

Trial Locations

United States3 trials

Canada3 trials

Australia2 trials

New Zealand2 trials

Puerto Rico1 trial

Trials often recruit across multiple countries, so totals exceed the trial count.

4 Trials

Phase 3Recruiting

NCT06172296

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

Sponsor:National Cancer Institute (NCI)

United StatesStarted: Apr 2024Est. completion: Dec 2029Updated: Mar 2026

Phase 3Recruiting

NCT03126916

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

Sponsor:Children's Oncology Group

United StatesStarted: May 2018Est. completion: Sep 2030Updated: Feb 2026

Phase 2Not Yet Recruiting

NCT06858501

Comparing 123I-MIBG and 18F-MFBG Imaging in Patients With Newly Diagnosed, High Risk Neuroblastoma

Sponsor:Children's Oncology Group

Started: Jun 2026Est. completion: Dec 2028Updated: Mar 2026

Phase 2Active, Not Recruiting

NCT04385277

Treatment With Dinutuximab, Sargramostim (GM-CSF), and Isotretinoin in Combination With Irinotecan and Temozolomide After Intensive Therapy for People With High-Risk Neuroblastoma (NBL)

Sponsor:Children's Oncology Group

United StatesStarted: Dec 2020Est. completion: Sep 2027Updated: Oct 2025

Stay informed about clinical trials for Nodular Ganglioneuroblastoma.

Follow this disease to get updates when trials open, close, or change status.

Follow This Disease — Free

Already have an account? Sign in to manage your watchlists.

Data sourced from ClinicalTrials.gov via Kisho's automated pipeline. Trials refreshed every 4 hours for monitored diseases.

Last sync: March 20, 2026 at 7:06 PM

Nodular Ganglioneuroblastoma — Clinical Trials

Trial Landscape

By Approach

By Phase

Sponsor Types

Trial Locations

4 Trials

Open Trials3

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

Comparing 123I-MIBG and 18F-MFBG Imaging in Patients With Newly Diagnosed, High Risk Neuroblastoma

Active Trials1

Treatment With Dinutuximab, Sargramostim (GM-CSF), and Isotretinoin in Combination With Irinotecan and Temozolomide After Intensive Therapy for People With High-Risk Neuroblastoma (NBL)